Panaxium
PrivateLast Round
Grant
Nov 28, 2025
Company Overview
Panaxium is a bioelectronic medicine company that develops AI-enabled iontronic neurostimulation therapies and medical equipment to treat brain injuries and restore motor function.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panaxium Comparables
Compare Panaxium with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurosoft Bioelectronics | 81% | |
| Precision Neuroscience | 75% | |
| Motif Neurotech | 73% | |
Panaxium Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 28, 2025 | ||||
| Seed | Apr 10, 2023 |
Panaxium Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Brain Institute | Seed |
| Centre for Aging and Brain Health Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors grew 415% MoM, from 447 to 2.3K.
Panaxium Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Panaxium's valuation, stock price, and market status.